Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes

Overview of attention for article published in Nephrology Dialysis Transplantation, April 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

So far, Altmetric has seen 14 X posts from 14 X users, with an upper bound of 11,414 followers.

RT @onconephsociety: Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes ⁦@NDTsocial⁩ https://t.co/Np0bm6quW5

RT @onconephsociety: Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes ⁦@NDTsocial⁩ https://t.co/Np0bm6quW5

RT @onconephsociety: Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes ⁦@NDTsocial⁩ https://t.co/Np0bm6quW5

RT @onconephsociety: Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomes ⁦@NDTsocial⁩ https://t.co/Np0bm6quW5

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 10 additional X posts.